Known targets — ChEMBL curated mechanism
SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A
The experimentally established mechanism targets of Procainamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN1A known ✓ | P35498 | 1/20 | 0.60 |
| ▸ | SCN2A known ✓ | Q99250 | 1/20 | 0.60 |
| ▸ | SCN3A known ✓ | Q9NY46 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.97 |
| ▸ | TSHR | P16473 | 2/20 | 0.97 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.97 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.97 |
| ▸ | ACHE | P22303 | 1/20 | 0.97 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.97 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.97 |
| ▸ | POLB | P06746 | 2/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | THRB | P10828 | 1/20 | 0.68 |
| ▸ | ATM | Q13315 | 1/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.68 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.65 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Procainamide SCHEMBL9614531 | 1.00 | BLM (1.00) | BLMLMNAPMP22ALDH1A1TSHR | |
| Procainamide SCHEMBL10717171 | 0.98 | BLM (0.97) | BLMLMNAPMP22ALDH1A1TSHR | |
| Procainamide SCHEMBL9592794 | 0.98 | BLM (0.97) | BLMLMNAPMP22ALDH1A1TSHR | |
| Procainamide SCHEMBL5443536 | 0.98 | BLM (0.97) | BLMLMNAPMP22ALDH1A1TSHR | |
| Procainamide SCHEMBL9437783 | 0.98 | BLM (0.97) | BLMLMNAPMP22ALDH1A1TSHR | |
| Procainamide SCHEMBL23270847 | 0.98 | BLM (0.97) | BLMLMNAPMP22ALDH1A1TSHR | |
| Procainamide SCHEMBL9618624 | 0.98 | BLM (0.97) | BLMLMNAPMP22ALDH1A1TSHR | |
| Procainamide SCHEMBL15914 | 0.98 | ALDH1A1 (1.00) | BLMLMNAPMP22ALDH1A1TSHR | |
| Procainamide SCHEMBL28944214 | 0.97 | ALDH1A1 (0.97) | BLMLMNAPMP22ALDH1A1TSHR | |
| Procainamide SCHEMBL341750 | 0.95 | ALDH1A1 (0.94) | BLMLMNAPMP22ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5042 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4729064-A1 | DE-DIFFERENTIATED FIBROBLAST-CONDITIONED MEDIA FOR TREATING OR PREVENTING DISC DEGENERATION | FibroBiologics, Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| EP-3787647-B1 | DE-DIFFERENTIATED FIBROBLAST-CONDITIONED MEDIA FOR TREATING OR PREVENTING DISC DEGENERATION | FIBROBIOLOGICS INC (US) | 2026-04-15 | — | — | EP | claimed |
| EP-4691556-A2 | HUMANIZED ANTI-ACTH ANTIBODIES AND USE THEREOF | H. Lundbeck A/S (DK) | 2026-02-11 | — | — | EP | claimed |
| US-20250135164-A1 | Controlled Release Of A Hydrophilic Agent From A Coated Surface | BIOCOAT, INCORPORATED | 2025-05-01 | — | — | US | claimed |
| CN-119546605-A | Protein degradation agent | 苏州开拓药业股份有限公司 | 2025-02-28 | — | — | CN | claimed |
| US-12214146-B2 | Controlled release of a hydrophilic agent from a coated surface | BIOCOAT, INCORPORATED (US) | 2025-02-04 | — | — | US | claimed |
| WO-2024027694-A9 | PROTEIN DEGRADATION AGENT | 苏州开拓药业股份有限公司 | 2025-01-02 | — | — | WO | claimed |
| US-20240390364-A1 | Novel Pyridine Compositions and their use in methods for preventing or treating diseases, disorders and conditions | REID CHRISTOPHER BRIAN (US) | 2024-11-28 | — | — | US | claimed |
| US-20240350643-A1 | PROTEIN DEGRADATION AGENT | SUZHOU KINTOR PHARMACEUTICALS, INC. (CN) | 2024-10-24 | — | — | US | claimed |
| US-20240282425-A1 | AUTHENTICATION METHODS AND SYSTEMS FOR DISPENSED PRESCRIPTIONS | LOW GORDON KEITH (US) | 2024-08-22 | — | — | US | claimed |
| EP-0248447-B1 | SUSTAINED RELEASE FORMULATIONS | WARNER-LAMBERT COMPANY (US) | 1990-04-18 | — | — | EP | claimed |
| US-4851233-A | TABLET BINDER MIXTURE OF PROCAINAMIDE HYDROCHLORIDE OR SODIUM MECLOFENAMATE AND HYDROXY ETHYL CELLULOSE FOR MATRIX DISINTEGRATION | WARNER-LAMBERT COMPANY (US) | 1989-07-25 | — | — | US | claimed |
| US-4816264-A | PROCAINAMIDE HYDROCHLORIDE, DRUG DELIVERY | WARNER-LAMBERT COMPANY (US) | 1989-03-28 | — | — | US | claimed |
| US-4756911-A | Tablet core of procainamide hydrochloride and hydrocolloid gelling agents, binders, hydrophobic and hydrophilic polymers | E. R. SQUIBB & SONS, INC. (US) | 1988-07-12 | — | — | US | claimed |
| EP-0248447-A2 | Sustained release formulations | WARNER-LAMBERT COMPANY (US) | 1987-12-09 | — | — | EP | claimed |
| US-4610870-A | PROCAINAMIDE HYDROCHLORIDE | E. R. SQUIBB & SONS, INC. (US) | 1986-09-09 | — | — | US | claimed |
| EP-0189861-A2 | Percutaneous absorption accelerator for ionic water-soluble medicine | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1986-08-06 | — | — | EP | claimed |
| US-4252786-A | POLYVINYLPYRROLIDONE WITH CARBOXYVINYL HYDROPHILIC POLYMER, INSOLUBLE BUT RUPTURABLE FILM | E. R. SQUIBB & SONS, INC. (US) | 1981-02-24 | — | — | US | claimed |
| US-4008719-A | Osmotic system having laminar arrangement for programming delivery of active agent | ALZA CORPORATION (US) | 1977-02-22 | — | — | US | claimed |
| US-3965255-A | DRUG ENCAPSULATED IN OR COATED WITH A SOLVENT MEMBRANE | E. E. ELJIM ECOLOGY LTD. (IL) | 1976-06-22 | — | — | US | claimed |